Seeking Alpha

HHS
  Harte Hanks Inc. - NYSE

11/1/2014, 7:19 AM ET
  • Mayascribe | Send Message 28 Feb 2011

    Department of HHS awards vaccine developer Novavax (NVAX) $97MM contract; could be $179 total. Including AH trading, up 22% on the day.
    Reply
      HHS vs. ETF Alternatives
      Company Description
      Harte-Hanks, Inc., is a multi-channel marketing company. The Company offers a variety of integrated, multichannel, data-driven solutions for top brands around the globe.
      Sector: Services
      Country: United States